OASIS PHARMACEUTICALS, LLC
Oasis Pharmaceuticals - GPCRs - Pepducin Technology - PAR2
Lexington, United States · Founded 2015
- Headquarters
- Lexington, Massachusetts
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- pepducin.com
About
Oasis Pharmaceuticals is a clinical-stage biotech startup advancing Pepducin technology, which targets the intracellular surface of G-protein coupled receptors (GPCRs) including PAR2. The company is developing treatments for inflammatory, fibrotic, and metabolic disorders including MASH, IPF, and atopic dermatitis in collaboration with Tufts Medical Center.
Summary
OASIS PHARMACEUTICALS, LLC is a Biotech company based in Lexington, United States, founded in 2015.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oasis-pharmaceuticals-llc"><img src="https://indexed.vc/api/badge/company/oasis-pharmaceuticals-llc" alt="OASIS PHARMACEUTICALS, LLC on Indexed.vc" width="260" height="76" /></a>